201 related articles for article (PubMed ID: 30595157)
1. [Not Available].
Mery B; Rancoule C; Rowinski E; Bosacki C; Vallard A; Guy JB; Magné N
Bull Cancer; 2018 Dec; 105 Suppl 3():S280-S285. PubMed ID: 30595157
[TBL] [Abstract][Full Text] [Related]
2. [The therapeutic potential of ablative radiotherapy for metastatic renal cell cancer: a tumour deemed radiation resistant].
Coucke P; Jánváry Z; Jansen N
Rev Med Liege; 2014; 69 Suppl 1():94-100. PubMed ID: 24822313
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy for renal-cell carcinoma.
De Meerleer G; Khoo V; Escudier B; Joniau S; Bossi A; Ost P; Briganti A; Fonteyne V; Van Vulpen M; Lumen N; Spahn M; Mareel M
Lancet Oncol; 2014 Apr; 15(4):e170-7. PubMed ID: 24694640
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic Body Radiotherapy for Kidney Cancer: Ready for Prime Time?
Carrasco-Esteban E; Barrionuevo-Castillo P; Domínguez-Rullán J; Gómez-Aparicio MA; Ferri-Molina M; Sáez-Bueno P; Zalabarría-Zarrabeitia Z; Scorsetti M; Arcangeli S; López-Campos F; Couñago F
Clin Oncol (R Coll Radiol); 2023 Mar; 35(3):163-176. PubMed ID: 36443137
[TBL] [Abstract][Full Text] [Related]
5. When Surgery Is Not an Option in Renal Cell Carcinoma: The Evolving Role of Stereotactic Body Radiation Therapy.
Miccio J; Johung K
Oncology (Williston Park); 2019 May; 33(5):167-73, 177. PubMed ID: 31095714
[TBL] [Abstract][Full Text] [Related]
6. Definitive, high-dose-per-fraction, conformal, stereotactic external radiation for renal cell carcinoma.
Beitler JJ; Makara D; Silverman P; Lederman G
Am J Clin Oncol; 2004 Dec; 27(6):646-8. PubMed ID: 15577450
[TBL] [Abstract][Full Text] [Related]
7. Hypofractionated stereotactic radiotherapy and radiosurgery for the treatment of patients with radioresistant brain metastases.
Scorsetti M; Facoetti A; Navarria P; Bignardi M; De Santis M; Ninone SA; Lattuada P; Urso G; Vigorito S; Mancosu P; Del Vecchio M
Anticancer Res; 2009 Oct; 29(10):4259-63. PubMed ID: 19846983
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach.
Siva S; Kothari G; Muacevic A; Louie AV; Slotman BJ; Teh BS; Lo SS
Nat Rev Urol; 2017 Sep; 14(9):549-563. PubMed ID: 28631740
[TBL] [Abstract][Full Text] [Related]
9. Current Role of Radiotherapy for Renal-Cell Carcinoma: Review.
Dengina N; Tsimafeyeu I; Mitin T
Clin Genitourin Cancer; 2017 Apr; 15(2):183-187. PubMed ID: 27789182
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic radiosurgery with or without whole brain radiotherapy for patients with a single radioresistant brain metastasis.
Clarke JW; Register S; McGregor JM; Grecula JC; Mayr NA; Wang JZ; Li K; Gupta N; Kendra KL; Olencki TE; Cavaliere R; Sarkar A; Lo SS
Am J Clin Oncol; 2010 Feb; 33(1):70-4. PubMed ID: 19652578
[TBL] [Abstract][Full Text] [Related]
11. Radiobiology of vestibular schwannomas: mechanisms of radioresistance and potential targets for therapeutic sensitization.
Yeung AH; Sughrue ME; Kane AJ; Tihan T; Cheung SW; Parsa AT
Neurosurg Focus; 2009 Dec; 27(6):E2. PubMed ID: 19951055
[TBL] [Abstract][Full Text] [Related]
12. [A systematic review of radiotherapy for primary renal cell carcinoma].
Gladilina IA; Shabanov MA; Kushlinskii NE; Bliganov PI; Sergeev AN
Urologiia; 2022 Mar; (1):96-101. PubMed ID: 35274868
[TBL] [Abstract][Full Text] [Related]
13. Radiation therapy in renal cell carcinoma.
De Felice F; Tombolini V
Crit Rev Oncol Hematol; 2018 Aug; 128():82-87. PubMed ID: 29958634
[TBL] [Abstract][Full Text] [Related]
14. [Stereotactic body radiation therapy for primary kidney cancer].
Abancourt L; Le Guévelou J; Taillez A; Vu A; de Crevoisier R; Supiot S; Hennequin C; Chapet O; Blanchard P; Mirabel X; Lartigau É; Pasquier D
Cancer Radiother; 2023 Sep; 27(6-7):568-572. PubMed ID: 37543493
[TBL] [Abstract][Full Text] [Related]
15. Hypofractionated high-dose intensity-modulated radiotherapy (60 Gy at 2.5 Gy per fraction) for recurrent renal cell carcinoma: a case report.
Cho J; Kim GE; Rha KH; Ahn JB; Lee CG; Suh CO; Seong J; Keum KC; Kim SIe; Lee YH
J Korean Med Sci; 2008 Aug; 23(4):740-3. PubMed ID: 18756070
[TBL] [Abstract][Full Text] [Related]
16. Palliative irradiation for focally symptomatic metastatic renal cell carcinoma: support for dose escalation based on a biological model.
DiBiase SJ; Valicenti RK; Schultz D; Xie Y; Gomella LG; Corn BW
J Urol; 1997 Sep; 158(3 Pt 1):746-9. PubMed ID: 9258072
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic body radiotherapy for renal cell cancer and pancreatic cancer : Literature review and practice recommendations of the DEGRO Working Group on Stereotactic Radiotherapy.
Panje C; Andratschke N; Brunner TB; Niyazi M; Guckenberger M
Strahlenther Onkol; 2016 Dec; 192(12):875-885. PubMed ID: 27778052
[TBL] [Abstract][Full Text] [Related]
18. Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases.
Wang CJ; Christie A; Lin MH; Jung M; Weix D; Huelsmann L; Kuhn K; Meyer J; Desai N; Kim DWN; Pedrosa I; Margulis V; Cadeddu J; Sagalowsky A; Gahan J; Laine A; Xie XJ; Choy H; Brugarolas J; Timmerman R; Hannan R
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):91-100. PubMed ID: 28587057
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy and Renal Cell Carcinoma: A Continuing Saga.
Spyropoulou D; Tsiganos P; Dimitrakopoulos FI; Tolia M; Koutras A; Velissaris D; Lagadinou M; Papathanasiou N; Gkantaifi A; Kalofonos H; Kardamakis D
In Vivo; 2021; 35(3):1365-1377. PubMed ID: 33910814
[TBL] [Abstract][Full Text] [Related]
20. [Radiotherapy of oligometastases: Sequences and interactions with systemic therapies, example of kidney cancer].
Wespiser M; Goujon M; Nguyen Tan Hon T; Maurina T; Kleinclauss F; Créhange G; Thiery-Vuillemin A
Cancer Radiother; 2019 Dec; 23(8):896-903. PubMed ID: 31591034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
